Summarize Experience, Check Problems, Formulate Measures, Fully Deploy 2022 Work
Release time:
2022-02-08
News from our newspaper # February 25 and 26 , the group company held a business work analysis meeting to review and summarize the work situation in 2021 , arrange and deploy the work for the new year, and put forward work requirements. At the
meeting, various professional companies and directly affiliated enterprises made a report on the overall work situation of 2021 , focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and a work plan for 2021 . The functional departments and offices of the headquarters made a brief report on the annual work situation and the 2021 work plan. Xiang Chongping, deputy general manager of the group company, systematically combed the human resources development in 2021 from the current human resources structure, recruitment and resignation, training management, salary level and labor productivity, enterprise labor management, etc. Lan Xiaolong, head of finance, analyzed the company's profit and profit structure in 2021 , and pointed out the risk points that need attention in operation and management; chen Tianci, Chairman of the Board of Supervisors, analyzed the overall situation of technological transformation projects of various enterprises in the three years of 2019-2021 and the problems existing in the implementation process. Zhu Jianwei, secretary of the board of directors, analyzed the future risks that the company may encounter from the aspects of peak and listed companies in related industries in the year 2021 and the revision of listing rules. Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2021 , made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out that substantial progress has been made in the construction of key investment projects. Continue to strengthen management integration and effectively improve the management level; New achievements have been made in scientific and technological innovation and technological transformation. Overcoming the adverse effects of epidemic situation, power restriction and production restriction, efforts to expand sales; strengthen personnel training, selection and introduction, and optimize the salary system; to celebrate the centenary of the founding of the party and the study and education of party history as a starting point, strengthen party building and ideological and political construction, and enhance the cohesion and centripetal force of enterprises; strengthen the daily prevention and control of the new coronary pneumonia epidemic to ensure the safety and health of employees; and effectively enhance the corporate image, influence and reputation and other work highlights. In particular, the results of a series of technological transformation of Daye Peak are remarkable, many economic and technical indicators of Huang Ping Peak have reached the leading level in the industry, the market sales of Olopatadine Eye Drops, a new product of Peak Pharmaceutical, are progressing smoothly, and the legal work of the Office of the Board of Directors and the safety management measures of the Audit Performance Management Department are promoted. At the same time, it also focuses on some problems such as the decline in profit level, the slower-than-expected progress of new projects, the higher labor productivity of production lines, the insufficient innovation ability of research and development capability, the outdated ideas and thinking modes of management personnel, the unsatisfactory construction of talent team, and the rise of the phenomenon of "three violations " .
Based on the current macroeconomic situation and the future trends of various related industries, Yu Jianhong, on behalf of the Group, proposed the working policy of 2022 as "Reform, Breakthrough, Innovation, Development " , and around this policy, proposed the key work of 2022 , with emphasis, planning for the future development of "second curve " , breaking through the development bottleneck and quickly entering a new growth track is the company's current top priority. Under the company's existing system and mechanism, it is necessary to solve the three problems of development motivation, development concept and development ability, that is, to stimulate development motivation through cultural identity, value feelings and incentive evaluation. Advocate the development concept of "to be user-oriented, supported by technology, efficiency, value and mode leadership, and build a value chain or ecological circle " ; with excellent talents, efficient team and organizational structure to improve the enterprise to capture opportunities, operations integration, resource mining, risk identification and other development capabilities. It is hoped that management cadres at all levels will practice themselves, be strict with themselves, and vigorously advocate a truth-seeking and pragmatic work style. Management cadres will take the lead in telling the truth, doing practical things, seeking practical results, not engaging in formalism, and not making superficial articles; always maintain a spirit of forge ahead and never slack off The state of mind and the attitude of daring to break through and work, and resolutely put an end to the negative tendency of waiting, relying, relying, and demanding; vigorously advocate the work style of "to efficiency " , and resolutely put an end to the bad atmosphere of prevarication, discussion but not decision, and only saying but not doing. Vigorously advocate the work style of "raising enterprises as their own children " , put yourself in the position of seeking things, keep improving things, and strive to achieve perfection in every work; vigorously advocate "thrifty enterprise " work style, spend every penny on the blade, control every cost to the lowest, and improve the market competitiveness of enterprises and products. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his affirmation and gratitude to all enterprises for their efforts and achievements in 2021 , commented on their resource acquisition ability, team morale, internal system construction, employee centripetal force, etc., and hoped that all enterprise management teams would seriously reflect, efforts to improve the communication ability at work, the determination and responsibility of handling affairs, and be able to discover and solve problems with a more systematic thinking and a more comprehensive perspective. Jiang Xiaomeng pointed out that in the future work, "cost reduction " will always be the main tone and the most basic competitiveness for enterprises to participate in market competition. The intelligence and digitization of production enterprises for the purpose of improving labor productivity is the general trend, and we must speed up the in-depth development. Innovation work such as technological transformation and new drug research and development should be strengthened and accelerated; new investment projects need to spend more energy to accelerate. He emphasized that management teams at all levels must unify their thinking, clarify management relationships, and establish a sound system in order to better improve the team's combat effectiveness and work passion, and promote the better development of the enterprise. (Reporter Fu Yiwu)
More information
Two Cement Enterprises Prosperous Production and Sales in May
With the gradual easing of the new crown epidemic, all over the project has started, Hubei, Yunnan two provinces cement market continued to improve, Daye peak cement company, Yunnan peak cement company two enterprises have recently shown a good momentum of production and sales. In May, the sales volume of Yunnan Jianfeng cement continued to rise. As of the time of publication, the average daily shipment volume reached more than 7400 tons, and the highest daily shipment volume reached more than 8700 tons, and the production capacity was fully released. Over the past few days, Yunnan Peak Packaging System has made great efforts to overcome the impact of narrow distribution sites and many cement varieties to ensure the completion of delivery tasks with good quality and quantity every day. In order to further balance production and sales and create conditions for the homogenization of cement delivered from the factory, Yunnan peak packaging system puts forward work requirements for relevant posts, emphasizes equipment inspection and process inspection during production, strictly implements safety operation procedures, and maintains safe and efficient operation of the system. Due to the impact of the new crown epidemic, Hubei cement market started late, Wuhan market is the hardest hit area, the current project construction is still not fully started, the volume pressure is greater. For this reason, daye peak departments cooperate closely, increase market development efforts, develop new mixing stations, focus on increasing the bulk share of Xianning, Huanggang and Wuhan markets, seize the opportunity of fine weather, and achieve the goal of rapid output. Internally, on the basis of equipment technical renovation and production capacity improvement, the delivery is effectively guaranteed, and the daily delivery capacity can basically be maintained at 10,000 tons. In May, Daye Peak sold more than 300000 tons of cement, an increase of 20% over the same period last year, with an average daily sales volume of more than 9900 tons, the highest in the current period since Daye Peak was put into production.
2020
07-31
The company's "safe production month" activities are about to start
June 2020 is the 19th national "safe production month", the theme of the activity is "eliminating hidden dangers of accidents and building a strong line of defense". A few days ago, the group company issued a notice to arrange the activities related to the organization of "safe production month" and put forward requirements. According to the group's "safe production month" activity plan, different key thematic activities will be held in the four weeks of June. The first week is the "Publicity and Safety Education Week", which focuses on the use of WeChat groups, electronic screens, publicity boards, banners, slogans and other forms for safety publicity, and organizes the study of national safety regulations, company safety system specifications and accident-free factory creation standards, Organize to watch safety warning education films, learn accident cases, etc., and improve employees' safety awareness by creating a safety atmosphere and organizing learning activities. The focus of the activities in the second week is "looking for potential sources of danger around you". Each unit takes departments and teams as units to investigate and analyze the potential risk factors in the process of daily production, maintenance and operation, find out the hazard sources that have not been included in the scope of risk point control, and report to the safety management department of the unit to form a risk assessment report, put forward solutions or suggestions, and supervise the implementation of rectification and timely eliminate potential safety hazards. The third week is the "on-site safety innovation achievements exhibition week", which focuses on the achievements of each unit in on-site safety management and on-site safety facilities in the past year, which are displayed in the form of pictures and texts through beautiful articles and wechat, so as to learn from each other and promote common progress. The fourth week is the "safety training and drill week", and the group company organizes the standardization of safety production and the elimination of hidden dangers.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-31
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-30
Jianfeng Pharmaceuticals ranks among the top 50 creative enterprises in Jinhua
News from our newspaper April 26 is World Intellectual Property Day. Jinhua City released the list of "Top 50 Creative Enterprises" for the first time. Jianfeng Pharmaceutical Company entered the list and ranked second among the enterprises in Jinhua Development Zone. The selection of creative enterprises, the enterprise holds the effective invention patent as the main indicator. Over the years, Jianfeng Pharmaceutical Co., Ltd. has taken "intellectual property rights help enterprise development, and scientific and technological innovation creates a century-old peak" as the company's intellectual property policy. It has actively cooperated with China Pharmaceutical University, Sichuan Institute of Antibiotic Industry, Zhejiang University of Technology, Xiamen University and other units to build a scientific research and innovation platform integrating production, learning and research, and flexibly introduced Academician Wang Guangji and Academician Shan Weiguang with the chief scientist system, according to the direction of enterprise development strategy to carry out scientific research work, and achieved fruitful results. In 2019, Spike Pharmaceuticals applied for 2 invention patents and obtained 5 patent authorizations, including 1 invention. By the end of 2019, Spike Pharmaceuticals had obtained a total of 37 patents (including 2 PCT patents), of which 28 were inventions. In recent years, in order to better integrate with the international market, Jianfeng Pharmaceutical has made a complete patent layout for the new drug DPT under development, and has applied for patent protection in multiple countries through the PCT application channel for core patents, and finally in the high-level United States. And Japan was authorized to lay a solid foundation for the product to enter these two overseas high-end markets. At the same time, around the core patent, applied for the preparation, crystal type patent and obtained the invention patent authorization 5. In addition, pharmaceutical companies have also developed patents for other varieties under research.
2020
07-22
On April 24, Jiang Xiaomeng, chairman of the group company, presided over the 14th meeting of the 10th board of directors of the company, and deliberated and passed 14 related reports and motions such as the 2019 annual board of directors report, the 2019 general manager business report and the 2019 annual report. The general manager's report pointed out that 2019 is the first year of the implementation of the group's new five-year strategic development plan (2019-2023) and the new three-year business plan (2019-2021) for each business sector. the management team has carried out various operation and management work in an orderly manner around the general policy of "innovation and reform, integration and promotion, scientific layout and steady development", and has better completed the business objectives set by the board of directors at the beginning of the year. In the whole year, the company achieved a total operating income of 3.548 billion billion yuan, an increase of 5.51 percent over the same period last year; net profit attributable to shareholders was 0.725 billion billion yuan, with earnings per share reaching 2.11 billion yuan, an increase of 23.14 percent over the same period last year, a record high; total assets at the end of the year were 5.475 billion billion yuan, an increase of 11.71 percent over the same period last year; and net assets attributable to shareholders were 3.789 billion billion yuan, an increase of 19.81 percent. During the reporting period, the company's two main businesses have achieved great development, benefiting from the further promotion of supply-side structural reform, the overall operation of the cement industry in 2019 is stable, and the industry benefits are further improved. During the reporting period, the company made new progress in the construction of cement projects, completed the acquisition, capital increase and name change of Guizhou Mingchuan (Guizhou Huangping Jianfeng Cement Co., Ltd.), and continued to invest in the construction of its new dry cement production line with a daily output of 4500 tons of clinker.
2020
07-31